SIGMOLECS®
Innovative Solutions in Regenerative Medicine
Based in Switzerland, our company pioneers the development of cutting-edge substance-based products within the field of regenerative medicine. Leveraging our SIGMOLECS® concept, we create unique topical formulations combining proven and innovative ingredients. Our product lines address two key areas: musculoskeletal (MSK) disorders, focusing on pain management and joint health, and dermo-aesthetic, where we offer solutions designed to support the skin’s natural regenerative processes. Each formula is meticulously designed to enhance the bioavailability and penetration of active ingredients, promoting the body’s natural physiology and offering effective, non-invasive solutions for medical professionals and patients alike. Our products are becoming globally accessible, already with presence in several international markets.
Evidence-based product lines
All the products are backed by rigorous scientific research: as a scientifically driven and evidence-oriented company, we continuously promote clinical studies to validate the efficacy and safety of our formulations. Our commitment to patient safety and well-being is paramount, ensuring a favourable benefit-risk ratio while delivering high-quality, practical solutions that limit the need for clinical visits, making our professional protocols effective, safe and convenient for the patients. By collaborating with forward-thinking partners worldwide, we aim to expand our reach and redefine standards in regenerative medicine for MSK disorders and aesthetic medicine.
